SEC FORM 4
$76,626.45
OCULAR THERAPEUTIX, INC (OCUL)
Sale of 10,869 shares at $7.05 per share.
Reporting Person Heier Jeffrey S. · Officer Title Chief Scientific Officer · Transaction Code S
Traded Oct 2, 2026 · Disclosed Oct 6, 2026
Source: SEC Form 4 · 0001104659-26-114080 · filed 2026-10-06 · View filing →